Search results
Matthew Perry’s death investigation: Here’s what we know
The Independent via Yahoo News· 2 days agoThe coroner noted that the ketamine in Matthew’s system “could not be from that infusion therapy,...
Edward L. Kuntz Sells 2,500 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) Stock
ETF DAILY NEWS· 7 days agoU.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) Director Edward L. Kuntz sold 2,500 shares of U.S. Physical Therapy stock in a transaction that ...
Pulmatrix (NASDAQ:PULM) Share Price Crosses Above 50 Day Moving Average of $1.87
ETF DAILY NEWS· 7 days agoPulmatrix, Inc. (NASDAQ:PULM – Get Free Report) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $1.87 and traded as high as $1.98 ...
Needham & Company LLC Reaffirms Buy Rating for Celcuity (NASDAQ:CELC)
ETF DAILY NEWS· 6 days agoNeedham & Company LLC reaffirmed their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a report published on Thursday, Benzinga reports. The firm currently has a $24.00 price ...
Savara (NASDAQ:SVRA) Price Target Cut to $7.00
ETF DAILY NEWS· 5 days agoSavara (NASDAQ:SVRA – Free Report) had its price objective cut by Evercore ISI from $10.00 to $7.00 in a research note issued to investors on Thursday morning, Benzinga reports ...
Here's How Much a $1000 Investment in ResMed Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 1 day agoThis includes out-of-hospital software platforms designed to support professionals and caregivers...
RAPT Therapeutics (NASDAQ:RAPT) Stock Rating Reaffirmed by Wolfe Research
ETF DAILY NEWS· 7 days agoWolfe Research reissued their peer perform rating on shares of RAPT Therapeutics (NASDAQ:RAPT – Free Report) in a research note issued to investors on Tuesday, Marketbeat.com ...
... Patient Care While Easing Operational Demands With Rehab Therapy’s First AI-Integrated EMR |...
Healthcare Dive· 2 days agoFrom front desk operations to back office billing, SPRY Ally shortens time-intensive processes such as securing and verifying patient insurance and obtaining pre-authorization approval for treatment ...
HC Wainwright Analysts Cut Earnings Estimates for Spruce Biosciences, Inc. (NASDAQ:SPRB)
ETF DAILY NEWS· 7 days agoSpruce Biosciences, Inc. (NASDAQ:SPRB – Free Report) – Equities researchers at HC Wainwright cut their Q2 2024 EPS estimates for Spruce Biosciences in a research note issued ...
Sarepta Therapeutics (NASDAQ:SRPT) PT Raised to $179.00
ETF DAILY NEWS· 6 days agoSarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its target price hoisted by Mizuho from $145.00 to $179.00 in a report issued on Friday, Benzinga reports. The firm presently has a “ ...